The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Industry Session

IS1-11

CLL treatment strategy and recent advances

Fri. Oct 12, 2018 1:50 PM - 2:20 PM No.11 (Osaka International Convention Center, 10F 1004-5)

Chair: Hiroaki Fujimori (Oncology Department, Medical Affairs Division, Janssen Pharmaceutical K.K.)

Sponsor: Janssen Pharmaceutical K.K.

[IS1-11] CLL treatment strategy and recent advances

Carol Moreno Atanasio (Hematology Department, Hospital de la Santa Creu i Sant Pau)